UK markets open in 3 hours 25 minutes
NIKKEI 225
39,155.16 +117.00 (+0.30%) HANG SENG
18,060.68 -306.27 (-1.67%) CRUDE OIL
77.58 -0.16 (-0.21%) GOLD FUTURES
2,320.20 -6.80 (-0.29%) DOW
38,868.04 +69.05 (+0.18%) Bitcoin GBP
53,689.06 -1,051.25 (-1.92%)
EW Jan 2026 100.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:44AM EDT. Market open.
Loading interactive chart…
- Zacks
HOLX vs. EW: Which Stock Should Value Investors Buy Now?
HOLX vs. EW: Which Stock Is the Better Value Option?
- Zacks
BD (BDX) Inks Buyout Deal to Expand Smart Connected Care Suite
BD's (BDX) latest agreement is likely to unlock new future value-creation opportunities and expand its portfolio of smart connected care solutions.
- Business Wire
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
NEW YORK, June 05, 2024--Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve patients there were excellent clinical outcomes and valve durability irrespective of the patient’s annulus size or sex. These data were presented during the late-breaking clinical
© 2024 Yahoo. All rights reserved.